CDxDiagnostics_Logo.png
WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City
09 mars 2021 11h00 HE | CDx Diagnostics
SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- WATS3D, a diagnostic platform used by physicians to detect Barrett’s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a...
CDxDiagnostics_Logo.png
WATS3D Now Considered Medically Necessary by BlueCross BlueShield of South Carolina
26 janv. 2021 14h00 HE | CDx Diagnostics
SUFFERN, N.Y., Jan. 26, 2021 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and cancerous cells in the esophagus, is now...
CDxDiagnostics_Logo.png
CDx Diagnostics Awarded Federal Supply Schedule Contract
15 déc. 2020 11h30 HE | CDx Diagnostics
Veterans now have access to WATS3D life-saving technology in the VA and community settings SUFFERN, N.Y., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CDx Diagnostics has been awarded GSA Contract...
CDxDiagnostics_Logo.png
Study Confirms WATS3D as Cost-Effective Adjunct to Seattle Protocol
25 août 2020 13h00 HE | CDx Diagnostics
The addition of WATS3D to the screening process for BE resulted in approximately 3 fewer cancers and 3 fewer cancer deaths per 1,000 people screened SUFFERN, N.Y., Aug. 25, 2020 (GLOBE NEWSWIRE) --...
CDxDiagnostics_Logo.png
SAGES TAVAC Analysis Indicates WATS3D is a Safe and Effective Diagnostic Technique for Barrett’s Esophagus
16 juin 2020 13h00 HE | CDx Diagnostics
SUFFERN, N.Y., June 16, 2020 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform used to identify precancerous cells in the esophagus, has been deemed as a safe and effective adjunctive to...